Nanotechnology Expert

---
name: nanotechnology-expert
version: 1.0.0
description: Expert-level nanotechnology covering nanomaterials, nanofabrication, characterization methods, nanoelectronics, nanomedicine, and self-assembly.
author: luo-kai
tags: [nanotechnology, nanomaterials, nanofabrication, nanoelectronics, nanomedicine]
---

# Nanotechnology Expert

## Before Starting
1. Which nanomaterial class? (carbon, metal, semiconductor, polymer)
2. Synthesis, characterization, or application focus?
3. Electronics, medicine, or energy application?

## Core Expertise Areas

### Nanomaterials
Carbon nanotubes: cylindrical graphene, metallic or semiconducting depending on chirality.
Graphene: single atom carbon layer, exceptional electrical and mechanical properties.
Quantum dots: semiconductor nanocrystals, size-tunable optical properties.
Gold nanoparticles: surface plasmon resonance, bioconjugation, drug delivery.
Nanocomposites: nanomaterial reinforced matrix, enhanced mechanical and barrier properties.

### Nanofabrication
Top-down: lithography removes material from bulk, current CMOS at 2nm node.
Bottom-up: atomic and molecular assembly, self-assembly, CVD growth.
EBL: electron beam lithography, sub-10nm resolution, slow and expensive.
Nanoimprint: pattern transferred by mechanical pressing, high throughput.
ALD: atomic layer deposition, conformal films one atomic layer at a time.

### Characterization
TEM: transmission electron microscopy, atomic resolution imaging.
SEM: scanning electron microscopy, surface morphology, nanometer resolution.
AFM: atomic force microscopy, surface topology, mechanical properties at nanoscale.
XPS: x-ray photoelectron spectroscopy, surface chemical composition.
Raman spectroscopy: molecular vibrations, identify carbon allotropes and defects.

### Nanomedicine
Drug delivery: nanoparticles encapsulate drugs, targeted release to tumor.
EPR effect: enhanced permeability and retention of nanoparticles in tumor tissue.
Liposomes: lipid vesicles, biocompatible drug carriers, approved clinical use.
Theranostics: combined therapeutic and diagnostic nanoparticles.
Toxicology: size and surface chemistry determine nanotoxicity, must be assessed.

## Best Practices
- Characterize nanomaterials with multiple techniques to confirm properties
- Control size distribution carefully as properties vary strongly with size
- Assess toxicity before biomedical application
- Document synthesis conditions precisely for reproducibility

## Common Pitfalls
| Pitfall | Fix |
|---|---|
| Assuming bulk properties at nanoscale | Surface effects dominate, properties change dramatically |
| Ignoring aggregation | Nanoparticles aggregate in biological media, measure hydrodynamic size |
| Poor size control | Optimize synthesis conditions, use size-selective precipitation |
| Neglecting surface chemistry | Surface determines colloidal stability and bio-interaction |

## Related Skills
- physics/condensed-matter-expert
- chemistry/materials-chemistry
- biomedical/biomaterials-expert